Latest GK GS

Updated By: LatestGKGS Desk

Supreme Court removes banning of Saridon & 3 other FDCs

 

 

Supreme Court removes banning of Saridon & 3 other FDCs: Details, Verdict, Background, Highlights

The Supreme Court of India on 17th September 2018 removed the banning and allowed the sale of popular painkiller Saridon and three other banned fixed-dose combinations (FDCs) in medical stores across India.

The Supreme Court ruling was ruled by a two bench of judges comprising Justices R F Nariman and Indu Malhotra.

The SC has also issued a notice to the centre and sought its reply on the plea filed by some drug makers and pharma associations.

The SC has allowed the sale of Piramal Healthcare's Saridon, GlaxoSmithKline's Piriton, Juggat Pharma's Dart and another drug, the details of which are not known.

Background

Union Health Ministry issued a notification last week prohibiting the manufacture, sale, and distribution of 328 Fixed Dose Combinations (FDCs) for human use with immediate effect.

Health Ministry also restricted the manufacture, sale, and distribution of six FDCs subject to certain conditions. The action was taken by the Ministry under the powers conferred by section 26A of the Drugs and Cosmetics Act, 1940.


 

Latest Supreme Court Updates

» Daily Current Affairs 15th September 2018 GK GS Bulletins

» Isro spy case: SC orders Rs 50 lakh compensation to scientist S Nambi Narayanan

» Supreme Court modifies its anti-dowry harassment law 'IPS Section 498A'

» Union Health Ministry New Health Warnings on Tobacco Products Packs From 1st Sep 2018

» Government of India Bans Oxytocin Growth Hormone To Restrict Misuse From 1 July 2018